Hospital

Study also showed that 76% of individuals treated with lecanemab-irmb had no deterioration in the tau positron emission tomography (PET) subset.

The approval marks the first new biologic treatment option for this patient population in nearly a decade.

Patients who are immunocompromised generally had worse risk and severity of CDI.

Nick Gazda, PharmD, MS, BCPS, CSP assistant director of Specialty Pharmacy Services, discusses how the pharmacy landscape is constantly changing, leading pharmacists to remain nimble and open.

Calvin Tucker, PharmD, MBA, FCCM, FFSHP, Pharmacy Manager for the Cancer Care Pharmacy discusses the unique and valuable role pharmacist have within the health care community

Coloring can be a form of mindfulness and promotes relaxation and reduces stress, which is particularly valuable in the fast-paced world of health care.

A well-executed, human-like digital relationship can transform patient engagement to patient activation.

3D printing tablets allow for the customization of medication based on individual patient needs, including factors such as age, weight, and specific medical conditions.

In a clinical trial, 2 vonoprazan-based regimens demonstrated higher rates of eradication as well as low rates of adverse effects compared to lansoprazole triple therapy.

Developing writing samples and networking are examples of strategies for students to develop their skills in medical writing.

Pharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.

Crystal Toribio, PharmD, Transitions of Care Clinical Pharmacist at St. Francis Hospital discusses the impact of direct patient care within her role to highlight this American Pharmacists Month.

Anemic individuals with heart failure with preserved ejection fraction displayed unique pathophysiological features that led to reduced exercise capacity.

Kate Smullen, PharmD, CSP, MSCS, senior director of clinical services at Shields Health Solutions, discussed her journey to becoming a pharmacist and how she has been celebrating this American Pharmacists Month.

Amber Bush, PharmD, RPh, BCPS, BCCCP, pharmacy research coordinator for Mayo Clinic discusses the future of pharmacy through her role within research clinical trials

Ramesh Cheruvu, PharmD, pharmacist and pharmacy manager at Health Mart Family Pharmacy at McKesson, discussed his journey in the pharmaceutical industry and how it has changed since he became a pharmacist.

RFID technology encompass a wide range of applications, including inventory management, medication authentication, patient adherence, and workflow efficiency.

Study finds that probable insomnia disorder was associated with physical health problems and difficulty with anger in veterans.

However, uncomplicated diabetes was not significantly linked to a greater risk of all-cause mortality or death from colorectal cancer.

With a new administration protocol created specifically for the routine clinic, infectious disease physicians can treat recurrent clostridioides difficile infection in less than 3 weeks.

Although everyone’s residency looks different, it is important for mothers to assess childcare options, be transparent about their schedule, and take care of themselves.

Mirikizumab-mrkz (Omvoh; Eli Lilly and Company) is the first IL-23p19 antagonist approved for adult patients with moderately to severely active ulcerative colitis.

Christina Barrington, PharmD, vice president of pharmacy programs at Priority Health, discusses current disruptors in the marketplace and high-cost drugs.

Sotagliflozin (Inpefa) is an orally administered dual SGLT1/2 inhibitor that reduces the risk of death due to heart failure.

Arexvy shows efficacy in helping protect adults aged 50 to 59 years with an increased risk for respiratory syncytial virus lower respiratory tract disease.

A critical aspect of National Prescription Drug Take Back Day is the focus on Naloxone training.

Semaglutide was found to be the most effective drug for weight loss, but the benefits may not outweigh the cost associated with treatment.

The drug’s mode of action is different than other types of corticosteroids because it’s based in the differential effects on glucocorticoid and mineralocorticoid receptors.

The vice president of pharmacy operations at American Oncology Network discusses the 340B Drug Pricing Program and its growth and impact on community oncology.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses SDOH and how pharmacists, particularly within community pharmacies, are the most accessible health care providers and can play a crucial role in advocating for patients.